Cardiovascular Intervention and Therapeutics

, Volume 33, Issue 2, pp 109–115 | Cite as

Predictors of early restenosis after intracardiac echocardiography guided antegrade balloon aortic valvuloplasty in high-risk or inoperable patients

  • Shinobu Hosokawa
  • Yoshikazu Hiasa
  • Akiho Seno
  • Tatuo Yasuoka
  • Tomoko Izumi
  • Riyo Ogura
Original Article


Antegrade balloon aortic valvuloplasty (BAV) may be more effective than retrograde BAV. However, early restenosis is found inconstantly within three months after BAV. To evaluate the factor of ER after intracardiac echocardiogram (ICE) guided Antegrade BAV, fifty patients with severe aortic stenosis (AS) underwent BAV procedures with ICE. ER was defined as mean aortic valve pressure gradient (PG) >40 mmHg. During one-year follow-up period, 6 patients died and 2 patients underwent aortic valve replacement. ER was present in 13 patients (26%) at three months after BAV. Procedural, clinical, and hemodynamic data were collected. The mean age of the patient population was 85.4 ± 7.6 years; the mean STS score and EuroSCORE were 7.8 ± 1.1 and 14.6 ± 4.1, respectively. The mean aortic valve PG decreased from 63.4 ± 19.8 to 28.5 ± 10.1 mmHg (p < 0.0001). Baseline characteristics were similar between the two groups. There is no significant difference of mean aortic valve PG immediate after BAV(ER; 29 ± 8.8 mmHg, nonER; 21 ± 6.1 mmHg, p = ns). Univariate analysis showed patients with ER group had significantly higher rate of left ventricular hypertrophy, pulmonary hypertension, and high mean aortic valve PG at admission. Multivariate analysis revealed high mean aortic valve PG at admission as independent predictors of ER. Antegrade BAV may be effective for severe AS. Left ventricular hypertrophy, pulmonary hypertension and high mean PG were predictor of early restenosis. Early intervention should be considered for these patients.


Aortic stenosis Antegrade balloon valvuloplasty Intracardiac echocardiography Early restenosis 


Compliance with ethical standards

This study complied with the Declaration of Helsinki in regard to investigation in humans and was approved by the institutional ethics committees at Tokushima red cross Hospital. There was no industry involvement in the design, conduct, financial support, or analysis of this study.

Conflict of interest

I have no disclosures/support grants and potential conflicts of interest.


  1. 1.
    Eltchaninoff H, Cribier A, Tron C, et al. Balloon aortic valvuloplasty in elderly patients at high risk for surgery, or inoperable. Immediate and mid-term results. Eur Heart J. 1995;16:1079–84.CrossRefPubMedGoogle Scholar
  2. 2.
    McKay RG. The mansfield scientific aortic valvuloplasty registry: overview of acute hemodynamic results and procedural complications. J Am Coll Cardiol. 1991;17:485–91.CrossRefPubMedGoogle Scholar
  3. 3.
    Ben-Dor I, Pichard AD, Satler LF, et al. Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. JACC Cardiovasc Interv. 2010;3:1150–6.CrossRefPubMedGoogle Scholar
  4. 4.
    Agarwal A, Kini AS, Attanti S, et al. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol. 2005;95:43–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Holmes DR Jr, Nishimura RA, Reeder GS. In-hospital mortality after balloon aortic valvuloplasty: frequency and associated factors. J Am Coll Cardiol. 1991;17:189–92.CrossRefPubMedGoogle Scholar
  6. 6.
    Letac B, Cribier A, Koning R, et al. Aortic stenosis in elderly patients aged 80 or older. Treatment by percutaneous balloon valvuloplasty in a series of 92 cases. Circulation. 1989;80:1514–20.CrossRefPubMedGoogle Scholar
  7. 7.
    Holmes DR Jr, Nishimura RA, Reeder GS. In-hospital mortality after balloon aortic valvuloplasty: frequency and associated factors. J Am Coll Cardiol. 1991;17:189–92.CrossRefPubMedGoogle Scholar
  8. 8.
    Don C, Gupta PP, Witzke C, et al. Patients with small left ventricular size undergoing balloon aortic valvuloplasty have worse intraprocedural outcomes. Catheter Cardiovasc Interv. 2012;15(80):946–54.CrossRefGoogle Scholar
  9. 9.
    NHLBI Balloon Valvuloplasty Registry Participants. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation. 1991;84:2383–97.CrossRefGoogle Scholar
  10. 10.
    Moreno PR, Jang IK, Newell JB, et al. The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J Am Coll Cardiol. 1994;23:1071–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Liu Z, McCormick D, Dairywala I, et al. Catheter-based intracardiac echocardiography in the interventional cardiac laboratory. Catheter Cardiovasc Interv. 2004;63:63–71.CrossRefPubMedGoogle Scholar
  12. 12.
    Cooper JM, Epstein LM. Use of intracardiac echocardiography to guide ablation of atrial fibrillation. Circulation. 2001;104(25):3010–3.CrossRefPubMedGoogle Scholar
  13. 13.
    Sakata Y, Syed Z, Salinger MH, et al. Percutaneous balloon aortic valvuloplasty: antegrade transseptal vs. conventional retrograde transarterial approach. Catheter Cardiovasc Interv. 2005;64:314–21.CrossRefPubMedGoogle Scholar
  14. 14.
    Khawaja MZ, Sohal M, Valli H, et al. Standalone balloon aortic valvuloplasty: indications and outcomes from the UK in the transcatheter valve era. Catheter Cardiovasc Interv. 2013;81:366–73.CrossRefPubMedGoogle Scholar
  15. 15.
    Lieberman EB, Bashore TM, Hermiller JB, et al. Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival. J Am Coll Cardiol. 1995;26:1522–8.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Association of Cardiovascular Intervention and Therapeutics 2017

Authors and Affiliations

  • Shinobu Hosokawa
    • 1
  • Yoshikazu Hiasa
    • 1
  • Akiho Seno
    • 1
  • Tatuo Yasuoka
    • 1
  • Tomoko Izumi
    • 1
  • Riyo Ogura
    • 1
  1. 1.Division of CardiologyTokushima Red Cross HospitalKomatsushimaJapan

Personalised recommendations